The neutrophil-lymphocyte ratio has a role in predicting the effectiveness of nivolumab in Japanese patients with metastatic renal cell carcinoma: a multi-institutional retrospective study

BACKGROUND: The neutrophil-lymphocyte ratio (NLR) is a well-known prognostic marker in various cancers. However, its role as a predictive marker for the effectiveness of nivolumab in patients with metastatic RCC (mRCC) remains unclear. We evaluated the relationships between the NLR and progression-f...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishiyama, Naotaka, hirobe, Megumi, Kikushima, Takuya, Matsuki, Masahiro, Takahashi, Atsushi, Yanase, Masahiro, Ichimatsu, Keisuke, Egawa, Masayuki, Hayashi, Norihiro, Negishi, Takahito, Masumori, Naoya, Kitamura, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382809/
https://www.ncbi.nlm.nih.gov/pubmed/32711491
http://dx.doi.org/10.1186/s12894-020-00679-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382809/
https://www.ncbi.nlm.nih.gov/pubmed/32711491
http://dx.doi.org/10.1186/s12894-020-00679-2

Ejemplares similares